VANCOUVER, BC / ACCESS Newswire / March 24, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...
The acquisition aligns with The Lockwood Group's ongoing growth strategy, which includes expanding market access and commercialization support services. In recent years, Nexus Health has broadened its ...
VANCOUVER, BC / ACCESSWIRE / November 20, 2023 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to provide further details on its clinical and ...
Vancouver, BC & Edinburgh, Scotland, March 05, 2026 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global ” or the “Company ”) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded ...
The pharmaceutical commercialization landscape is becoming increasingly complex. Tried and true paradigms for capturing market share and securing reimbursement must evolve in the face of demand for ...
Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue ...
VerifyU credentialing with patented ADIO & WiSA technologies to connect NFL alumni to benefits and statistical credentials, fans, venues and events with acoustic mobile quick response “We are focused ...
The TechCrunch Global Affairs Project examines the increasingly intertwined relationship between the tech sector and global politics. Quantum computers, sensors and communications networks have the ...
When the topic of technology commercialization strategies comes up, the most common options typically mentioned include the sale of a technology or building a business around technology by selling ...
VANCOUVER, BC / ACCESS Newswire / March 24, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery sys ...